Lin, L., Zhao, J., Kong, N., He, Y., Hu, J., Huang, F., . . . Cao, X. (2017). Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors. Oncotarget.
Citação norma ChicagoLin, Liping, Juanjuan Zhao, Ning Kong, Yan He, Jiazhu Hu, Fuxi Huang, Jianjun Han, and Xiaolong Cao. "Meta-analysis of the Incidence and Risks of Interstitial Lung Disease and QTc Prolongation in Non-small-cell Lung Cancer Patients Treated With ALK Inhibitors." Oncotarget 2017.
MLA citiranjeLin, Liping, et al. "Meta-analysis of the Incidence and Risks of Interstitial Lung Disease and QTc Prolongation in Non-small-cell Lung Cancer Patients Treated With ALK Inhibitors." Oncotarget 2017.